Cargando…
A Novel Integrated Metabolism-Immunity Gene Expression Model Predicts the Prognosis of Lung Adenocarcinoma Patients
Background: Although multiple metabolic pathways are involved in the initiation, progression, and therapy of lung adenocarcinoma (LUAD), the tumor microenvironment (TME) for immune cell infiltration that is regulated by metabolic enzymes has not yet been characterized. Methods: 517 LUAD samples and...
Autores principales: | Chen, Songming, Duan, Yumei, Wu, Yanhao, Yang, Desong, An, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361602/ https://www.ncbi.nlm.nih.gov/pubmed/34393804 http://dx.doi.org/10.3389/fphar.2021.728368 |
Ejemplares similares
-
A Novel Immune-Prognosis Index Predicts the Benefit of Lung Adenocarcinoma Patients
por: Bai, Yuquan, et al.
Publicado: (2022) -
FDX1 can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma
por: Zhang, Zeyu, et al.
Publicado: (2021) -
Characterization of lung adenocarcinoma based on immunophenotyping and constructing an immune scoring model to predict prognosis
por: Liu, Mengfeng, et al.
Publicado: (2022) -
Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors
por: Niu, Yuchun, et al.
Publicado: (2020) -
Mutations Status of Chemokine Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colon Adenocarcinoma
por: Lin, Anqi, et al.
Publicado: (2021)